FindTrial
Sign In

Homoeopathy in dengue prevention.

Effectiveness of Eupatorium perfoliatum as preventive in dengue fever outbreak â?? A cohort study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2017/01/007669
Enrollment
20000
Registered
2017-01-10
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Eupatorium Perfoliatum 30: Eupatorium perfoliatum medicine shall be given in 30 potency on every 7th day for 3 months duration. Total 12 doses shall be administered orally in 3 months.

Sponsors

Central Council for Research in Homoeopathy New Delhi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: • Healthy individuals of either sex, aged 1 year and above living in the same community • Informed consent by the family head • No symptom of dengue

Exclusion criteria

Exclusion criteria: • Symptoms of dengue like illness/ fever in last 7 days • Pregnant women and lactating mother

Design outcomes

Primary

MeasureTime frame
a. Changes in incidence of dengue fever. Timepoint: patient reporting with fever shall be assessed on weekly and further monthly intervals till 3 months.—

Secondary

MeasureTime frame
Changes in duration of symptoms in patients those who suffered from dengue fever. Timepoint: patient reporting with fever shall be assessed on daily and further weekly, monthly intervals till 3 months.—

Countries

India

Contacts

Public ContactDr RKManchanda

Central Council for Research in Homoeopathy

drdnayak@gmail.com011-28525388

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026